Category: Grants & Awards
Search News
Professor Victoria Sanz-Moreno recognised for major contributions in the fight against melanoma
17th October 2022
Congratulations to Professor Victoria Sanz-Moreno from Barts Cancer Institute at Queen Mary University of London who has received the Estela Medrano Memorial Award from the Society of Melanoma Research, which honours women who have made major contributions in the fight against melanoma.
Read more
The REMODEL project: Remodelling tumour microenvironments to improve immunotherapy
12th October 2022
Professor Fran Balkwill from Barts Cancer Institute at Queen Mary University of London has received a UK Research and Innovation (UKRI) Frontier Research grant of over £2 million to investigate the most effective ways to remodel cancers to enhance the effects of immunotherapy.
Read more
BCI researcher receives new Pancreatic Cancer UK Fellowship
20th July 2022
Congratulations to Dr Audrey Lumeau, Postdoctoral Researcher at Barts Cancer Institute, Queen Mary University of London, who has received a Career Foundation Fellowship from the charity Pancreatic Cancer UK to investigate chromosomal instability in pancreatic cancer and its role in therapy resistance.
Read more
BCI researcher joins global Cancer Grand Challenges team
16th June 2022
Dr Benjamin Werner from Barts Cancer Institute at Queen Mary University of London is part of a world-class team of researchers that has been selected to receive a £20m Cancer Grand Challenges award to tackle the challenge of extrachromosomal DNA, a major driver of tumour evolution present in around a third of cancers.
Read more
BCI researcher receives prestigious MRC grant to investigate how HPV infection develops into cancer
27th May 2022
Dr Sarah McClelland from BCI is part of a collaborative project that has secured £1.2 million in funding from the Medical Research Council to investigate the mechanisms leading to cancer development in cells infected with human papillomavirus.
Read more
£3.1 million for PROTECT trial
6th May 2022
Yorkshire Cancer Research has announced a £3.1 million grant for research led by Ranjit Manchanda to investigate the risks, benefits, and feasibility of introducing population-based genetic testing for ‘all’ women to find out if they are at high risk of cancer. Thousands of women living in Yorkshire and other parts of the UK will be offered tests as part of the PROTECT (Population based germline testing for early detection and cancer prevention) clinical trial.
Read more